Erlotinib is effective against FLT3‐ITD mutant AML and...

The FASEB Journal 2020 / 08 Vol. 34; Iss. 8

Erlotinib is effective against FLT3‐ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn

Cao, Zhi‐Xing, Guo, Chuan‐Jie, Song, Xiaominting, He, Jun‐Lin, Tan, Lu, Yu, Si, Zhang, Ruo‐Qi, Peng, Fu, Peng, Cheng, Li, Yu‐Zhi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
34
Journal:
The FASEB Journal
DOI:
10.1096/fj.201902922RR
Date:
August, 2020
File:
PDF, 978 KB
2020
Conversion to is in progress
Conversion to is failed